| Literature DB >> 31181096 |
Phiona Marongwe1, Paidamoyo Gonouya2, Thoko Madoda3, Vernon Murenje1, Mufuta Tshimanga3, Shirish Balachandra4, John Mandisarisa4, Vuyelwa Sidile-Chitimbire2, Sinokuthemba Xaba5, Batsirai Makunike-Chikwinya1, Marrianne Holec6, Scott Barnhart6,7,8, Caryl Feldacker6,8.
Abstract
INTRODUCTION: Ensuring quality service provision is fundamental to ZAZIC's voluntary medical male circumcision (MC) program in Zimbabwe. From October, 2014 to September, 2017, ZAZIC conducted 205,847 MCs. Passive surveillance recorded a combined moderate and severe adverse event (AE) rate of 0.3%; reported adherence to follow-up was 95%, suggesting program safety. Despite encouraging passive surveillance data, verification of data quality and accuracy would increase confidence in AE identification.Entities:
Mesh:
Year: 2019 PMID: 31181096 PMCID: PMC6557516 DOI: 10.1371/journal.pone.0218137
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the 27 AEs observed during tandem reviews.
| Site | Days of GS observation | Total Reviews | Observed AEs | Observed AE rate | |||
|---|---|---|---|---|---|---|---|
| AEs | Client Age (years) | AE severity | AE timing and Type | ||||
| Site 1 | 9 | 95 | 5 | 10 | Moderate | B-IN | 5.26% |
| 15 | Moderate | C-IN | |||||
| 10 | Moderate | B-IN | |||||
| 13 | Moderate | C-IN | |||||
| 10 | Moderate | B-IN | |||||
| Site 2 | 7 | 91 | 4 | 11 | Moderate | B-BL | 4.39% |
| 13 | Moderate | B-IN | |||||
| 10 | Moderate | C-IN | |||||
| 14 | Moderate | B-IN | |||||
| 26 | Moderate | C-IN | 4.04% | ||||
| 13 | Moderate | B-IN | |||||
| 15 | Moderate | C-IN | |||||
| 15 | Severe | B-IN | |||||
| 10 | Moderate | C-IN | 8.00% | ||||
| 10 | Severe | B-IN | |||||
| 13 | Moderate | C-IN | |||||
| 16 | Severe | B-OA | |||||
| 11 | Severe | B-IN | |||||
| 10 | Moderate | B-IN | |||||
| 11 | Moderate | B-IN | |||||
| 11 | Moderate | C-IN | |||||
| Site 5 | 6 | 100 | 11 | Severe | C-IN | 5.0% | |
| 10 | Moderate | B-IN | |||||
| 10 | Moderate | B-IN | |||||
| 10 | Moderate | B-IN | |||||
| 11 | Severe | B-IN | |||||
| Site 6 | 5 | 100 | 1 | 12 | Moderate | C-IN | 1.0% |
Timing of AE: B = AE occurred within 7 days post op, C = AE occurred after 7 days post-operative. Type of AE: IN-Infection, BL- Bleeding, OA- Swelling with Hematoma
Retrospective AEs found during AE form review.
| Number of Retrospective AEs Documented, Oct-Dec 2016 | ||||||
|---|---|---|---|---|---|---|
| Site | MC Register | MC CIF | MoHCCAE forms | In/Out patient | MRF | DHIS2 |
| 1 | 0 | 1 | 0 | 0 | 0 | 1 |
| 2 | 1 | 1 | 1 | 1 | 1 | 0 |
| 3 | 0 | 1 | 1 | 2 | 0 | 0 |
| 4 | 0 | 0 | 1 | 0 | 1 | 0 |
| 5 | 0 | 0 | 0 | 0 | 0 | 0 |
| 6 | 5 | 3 | 2 | 4 | 5 | 0 |
CIF-Client Intake Form, MRF- Monthly Return Form, DHIS2- District Health Information System 2.
Potential missed adverse events in 6 study sites: October 2014- September 2017.
| Reported | Potential unidentified AEs | |||||
|---|---|---|---|---|---|---|
| Site # | AEs | MCs | AE rate | |||
| 1 | 10 | 14707 | 0.072% | 5.26% | 735 | 725 |
| 2 | 22 | 13892 | 0.167% | 4.39% | 580 | 558 |
| 3 | 30 | 8174 | 0.386% | 4.04% | 314 | 284 |
| 4 | 31 | 17908 | 0.182% | 8.00% | 1361 | 1330 |
| 5 | 25 | 11242 | 0.234% | 5.00% | 534 | 509 |
| 6 | 39 | 6727 | 0.610% | 1.00% | 64 | 25 |
| Sum | 157 | 72650 | 0.227% | 4.62% | 3,588 | 3,431 |
| Pooled | 157 | 72650 | 4.62% | 3,189 | 3,032 | |
*Includes only moderate and severe AEs. Observed AE rates from Table 1. Expected AEs per site (d) was calculated by multiplying (0.95) the number of MCs reported over the passive surveillance period (b) by the observed active surveillance AE rate (c) to estimate the AEs that may have actually occurred over the 2014–2017 reporting period. Potential unidentified AEs were calculated by subtracting reported AEs from expected AEs per site.
**As only 95% of men adhered to follow-up visits, the values for expected AEs per site (d) were multiplied by 0.95. Sum: Cumulative reported totals across the 6 sites; average observed AE rates across sites; total expected and unidentified AEs calculated by summing data from sites 1–6. Pooled: Calculated using the overall average observed AE rate (4.62%) multiplied by the total reported MCs (72,650). 95% CIs are presented in parentheses.